Patents by Inventor Hsiao-fen LI

Hsiao-fen LI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Electronic device
    Patent number: 11972072
    Abstract: The present disclosure provides an electronic device including a first sensing circuit, a second sensing circuit and a power line. The first sensing circuit includes a first sensing unit and a first transistor, and a first end of the first sensing unit is coupled to a control end of the first transistor. The second sensing circuit includes a second sensing unit and a second transistor, and a first end of the second sensing unit is coupled to a control end of the second transistor. A first end of the first transistor and a first end of the second transistor are coupled to the power line.
    Type: Grant
    Filed: November 1, 2022
    Date of Patent: April 30, 2024
    Assignee: InnoLux Corporation
    Inventors: Shu-Fen Li, Chuan-Chi Chien, Hsiao-Feng Liao, Rui-An Yu, Chang-Chiang Cheng, Po-Yang Chen, I-An Yao
  • ATF3 induction compounds
    Patent number: 11365200
    Abstract: The invention relates to compounds for treating and/or preventing obesity and obesity-related disorders. Particularly, the invention provides chromanone derivatives used as ATF3 inducer and for treating and/or preventing obesity and obesity-related disorders such as heart disease, hypertension, hyperlipidemia and diabetes.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: June 21, 2022
    Assignees: TAIPEI MEDICAL UNIVERSITY, NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE, MINISTRY OF HEALTH AND WELFARE, ACADEMIA SINICA, BUDDHIST TZU CHI MEDICAL FOUNDATION
    Inventors: Heng Lin, Ming-jaw Don, Ching-feng Cheng, Jing-jy Cheng, Wen-shan Li, Hui-chen Ku, Hsiao-fen Li, Hsi-hsien Chen, W J Huang
  • ATF3 INDUCTION COMPOUNDS
    Publication number: 20200361950
    Abstract: The invention relates to compounds for treating and/or preventing obesity and obesity-related disorders. Particularly, the invention provides chromanone derivatives used as ATF3 inducer and for treating and/or preventing obesity and obesity-related disorders such as heart disease, hypertension, hyperlipidemia and diabetes.
    Type: Application
    Filed: March 22, 2018
    Publication date: November 19, 2020
    Inventors: Heng LIN, Ming-jaw DON, Ching-feng CHENG, Jing-jy CHENG, Wen-shan LI, Hui-chen KU, Hsiao-fen LI, Hsi-hsien CHEN, WJ HUANG